Classification of Proliferative Hepatocellular Lesions in Harlan Sprague–Dawley Rats Chronically Exposed to Dioxin-Like Compounds

Over the years, the most appropriate classification scheme for nodular proliferative lesions of the hepatocyte has been heavily debated. In the most recent guidelines there appears to be a consensus for classifying these lesions as hepatocellular adenoma, hepatocellular carcinoma, or regenerative hyperplasia. Also, large foci of cellular alteration may appear somewhat nodular. Some nodular hepatocellular lesions from a group of 7 studies of dioxin and dioxin-like compounds conducted by the National Toxicology Program did not readily fit into these categories. Some of these lesions had morphologic features consistent with hyperplasia. However, there was not sufficient morphological or biological evidence to conclude that the entire response was regenerative. In other instances, these lesions had some features resembling adenoma, but contained a prominent component of biliary epithelium and/or oval cells. This component does not appear to be well described in the literature, and while its presence suggested a nodule to be nonneoplastic, this is inconclusive. This paper describes the morphology of these lesions, as well as the diagnostic approach taken in this series of studies.

[1]  Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.

[2]  Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.

[3]  Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies). , 2006, National Toxicology Program technical report series.

[4]  A. Francavilla,et al.  Hepatic regeneration , 1991, Digestive Diseases and Sciences.

[5]  D. Sasse,et al.  Metabolic zonation in thioacetamide-induced liver cirrhosis , 2004, Histochemistry.

[6]  Randall G. Lee,et al.  Tumors of the liver and intrahepatic bile ducts , 2003, American Journal of Gastroenterology.

[7]  K. Imaida,et al.  A Review of Nomenclature and Diagnostic Criteria for Proliferative Lesions in the Liver of Rats by a Working Group of the Japanese Society of Toxicologic Pathology , 2003 .

[8]  G. Lucier,et al.  Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent. , 2001, Chemical research in toxicology.

[9]  D. Harrison,et al.  Apoptosis and carcinogenesis. , 1999, British journal of cancer.

[10]  P. Hytiroglou,et al.  Differential diagnosis of hepatocellular nodular lesions. , 1998, Seminars in diagnostic pathology.

[11]  Y. Nakanuma,et al.  Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease. , 1998, Histology and histopathology.

[12]  G. Lucier,et al.  Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver. , 1998, Carcinogenesis.

[13]  Paulina Belle Nissenblatt Liver , 1997, The Lancet.

[14]  M. Bernasconi Inhibition of apoptosis , 1997 .

[15]  A. Buchmann,et al.  Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. , 1995, Carcinogenesis.

[16]  C. Sarraf,et al.  Review : Apoptosis: regulation and relevance to toxicology , 1995 .

[17]  S. Thung,et al.  Macroregenerative nodules in a series of adult cirrhotic liver explants: Issues of classification and nomenclature , 1995, Hepatology.

[18]  C. Sarraf,et al.  Apoptosis: regulation and relevance to toxicology. , 1995, Human & experimental toxicology.

[19]  T. Terada,et al.  Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study. , 1994, The American journal of gastroenterology.

[20]  T. Terada,et al.  Adenomatous hyperplasia of the liver as a precancerous lesion. , 2008, Liver.

[21]  G. Clark,et al.  Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints. , 1993, Environmental health perspectives.

[22]  M. Kojiro,et al.  Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma , 1992, Hepatology.

[23]  J. Huff,et al.  Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. , 1991, Environmental health perspectives.

[24]  R. Peters,et al.  Tumors of the Liver and Intrahepatic Bile Ducts , 1990 .

[25]  J. Mead,et al.  Regulation of liver growth: protooncogenes and transforming growth factors. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[26]  F. Kondo,et al.  Large regenerative nodules and dysplastic nodules in cirrhotic livers: A histopathologic study , 1988, Hepatology.

[27]  D. V. van Thiel,et al.  Rapid growth of an intact human liver transplanted into a recipient larger than the donor. , 1987, Gastroenterology.

[28]  N. Nagasue,et al.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. , 1987, Annals of surgery.

[29]  D. V. van Thiel,et al.  Evidence that host size determines liver size: Studies in dogs receiving orthotopic liver transplants , 1987, Hepatology.

[30]  E. Mcconnell,et al.  National Toxicology Program Nomenclature for Hepatoproliferative Lesions of Rats , 1986, Toxicologic pathology.

[31]  J. Huff,et al.  Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. , 1984, Journal of toxicology and environmental health.

[32]  M. Greenblatt Tumours of the liver. , 1982, IARC scientific publications.

[33]  H. Pitot,et al.  Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. , 1980, Cancer research.

[34]  Histologic typing of liver tumors of the rat. Institute of Laboratory Animal Resources, National Research Council, National Academy of Sciences, Washington, D.C. , 1980, Journal of the National Cancer Institute.

[35]  C. Wade,et al.  Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. , 1978, Toxicology and applied pharmacology.

[36]  L. Sobin,et al.  The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.

[37]  R. Squire,et al.  Report of a workshop on classification of specific hepatocellular lesions in rats. , 1975, Cancer research.

[38]  A. E. Rogers,et al.  Animal model: fatty liver and cirrhosis in lipotrope-deficient male rats. , 1973, The American journal of pathology.